Biosimilars: Evidence From Europe
A look inside the European Union’s Biosimilar Market
Biosimilars Whitepaper | Biosimilars Evidence from Europe Whitepaper

More Whitepapers / Newsletters

Duchenne Muscular Dystrophy Newsletter
Duchenne Muscular Dystrophy

A genetic disorder, Duchenne Muscular Dystrophy (DMD), is a progressive form of muscular dystrophy with a higher preponderance in males; however, in some rare cases, it can occur in females too. As pe...

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Blastic Plasmacytoid Dendritic...

Blastic plasmacytoid dendritic cell neoplasm (BPDCN), an extremely rare form of neoplasm, generally affects the elderly male population. Cancer develops in bone marrow and blood. It involves multiple...

Lamellar Ichthyosis
Lamellar Ichthyosis

Lamellar Ichthyosis (LI) is an autosomal recessive congenital Ichthyosis (ARCI), which mainly affects the skin. It is a clinically and genetically heterogeneous group of dermatological scaly skin diso...

An Abundance Of Rare Newsletter
An Abundance Of Rare

Though appear rare, rare diseases are far from being rare. With over 7,000 rare disease affecting millions worldwide, Rare disease pose a huge burden on the global healthcare system, affecting the qua...

Multiple Myeloma Market
Multiple Myeloma

Multiple myeloma (MM) is a cancer of the blood that begins in the bone marrow. In myeloma, plasma cells develop into cancerous myeloma cells. Multiple myeloma is not widespread cancer; however, it has...